您的位置: 首页 > 农业专利 > 详情页

1-pyrazolyl-3-((4-((2-anilinopyrimidin-4-yl) oxy) napththalen-1-yl) ureas as p38 MAP kinase inhibitors
专利权人:
RESPIVERT LIMITED
发明人:
Kazuhiro Ito,Catherine Elisabeth Charron,John King-Underwood,Stuart Thomas Onions,Alistair Ian Longshaw
申请号:
US14349356
公开号:
US09475796B2
申请日:
2012.10.03
申请国别(地区):
US
年份:
2016
代理人:
摘要:
There are provided compounds of formula (I) which are inhibitors of the family of p38 mitogen-activated protein kinase enzymes, and to their use in therapy, including in pharmaceutical combinations, especially in the treatment of inflammatory diseases, including inflammatory diseases of the lung, such as asthma and COPD.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充